Green Thumb Industries Inc. (GTBIF)
(Delayed Data from OTC)
$13.20 USD
-0.16 (-1.20%)
Updated May 3, 2024 03:59 PM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Brokerage Reports
0 items in cart
Green Thumb Industries Inc. [GTBIF]
Reports for Purchase
Showing records 101 - 120 ( 124 total )
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Canada Update, Sales & Pricing Stabilizing
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Cannabis Sector Performance Analysis
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
U.S. Cannabis: Post 2Q22 U.S. Cannabis Takeaways
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Start Spreading the Licenses New York, New York
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
2Q22 Solid Beat, Scale & Efficiencies in Key States, NJ Upside, Reit Buy
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Two Thumbs Up as NJ/IL Retail Sales Drive Q222 Beat
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: MSO Uplisting Process, How SAFE Potentially Creates a Path
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Green Thumb Industries Inc.
Industry: Medical - Products
U.S. Cannabis 2Q22 Preview: Macro Impacting NT, Legislative Progess Warming
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Operating Income Gaining Investor Interest As Industry Matures
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Signs of Recovery But Increasing Taxes Payable Pose a Challenge for H2/22
Provider: PI Financial Corp.
Analyst: ZANDBERG J
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Consumer Access Key - Opening More Retail Licenses
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Deferred Taxes, Another Low "Cost" Cash Opportunity
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
NJ Adult-Use Cannabis Update: New Recreational Stores Added to Begin Sales
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
1Q22 Tough Margins, Looking Forward to 2H22 Acceleration, PT to $27
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Another Quarter of Solid Execution in a Period of Normalization
Provider: Echelon Welath Partners
Analyst: SEMPLE A